[Calcium antagonists in the treatment of coronary heart disease].
In the treatment of coronary heart disease calcium antagonists unfold a whole spectrum of effects, which favorably influence the clinical picture; dilation of the peripheral vessels, of the coronary arteries and of the particularly eccentric stenoses of the coronary vessels. The myocardial protection and an inhibition of the thrombocyte aggregation in the predamaged vessel area are also discussed as favorable effects of the calcium antagonists. It seems that the prevention of coronary spasms is especially important for patients, who have an angina at rest.
D000787:Angina Pectoris / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003329:Coronary Vasospasm / Q000188:drug therapy; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D002121:Calcium Channel Blockers; D002118:Calcium
Kalzium-Antagonisten in der Behandlung der koronaren Herzkrankheit.